# MASSACHUSETTS GENERAL HOSPITAL: CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | MASSACHUSETTS GENERAL HOSPITAL |
| Location | BOSTON, MA |
| Project | CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer |
| Project number | 5UH3CA283619-04 |
| Mechanism | UH3 |
| Institute | National Cancer Institute |
| Award | $2,493,876 |
| Awarded | 2026-09-17 |
| Project period | 2025-09-01 to 2028-08-31 |
| UEI | FLJ7DQKLL226 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11396191). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.